Exec-Edge – Page 50 – ExecEdge

Potbelly Net Income Up 150% in Q3 as Perks Drive Engagement

Potbelly Net Income Up 150% in Q3 as Perks Drive Engagement

By Karen Roman Potbelly Corp. (Nasdaq: PBPB) said net income increased 150% in the third quarter and adjusted EBITDA rose 19%, surpassing analysts’ expectations. Adjusted earnings per share was $0.08, up 100% compared to the year prior, while total revenue...

a.k.a. Brands U.S. Sales Up 20% in Q3, Shares Rise

a.k.a. Brands U.S. Sales Up 20% in Q3, Shares Rise

By Karen Roman Fashion brand accelerator a.k.a. Brands Holding Corp. (NYSE: AKA) said net sales rose 6.4% to $149.9 million in the third quarter, with U.S. net sales increasing 19.5%. Adjusted EBITDA was $8.2 million compared to $4.7 million in the...

Planet Fitness Increases FY Outlook Amid Strong Q3 Sales

Planet Fitness Increases FY Outlook Amid Strong Q3 Sales

By Karen Roman Planet Fitness, Inc. (NYSE:PLNT) said revenue grew 5.3% to $292.2 million in the third quarter and adjusted EBITDA increased 10% to $123.1 million. Net income was $42 million or $0.50 per share, compared to $39.1 million or...

Solo Brands Reaffirms FY 2024 Guidance

Solo Brands Reaffirms FY 2024 Guidance

By Karen Roman Solo Brands, Inc. (NYSE: DTC) said it is maintaining its full year outlook with total revenue between $470 million to $490 million and an adjusted EBITDA margin from 9% to 10%. Net sales were $94.1 million decreasing...

Portillo’s EPS Beat Analysts’ Estimates in Q3

Portillo’s EPS Beat Analysts’ Estimates in Q3

By Karen Roman Chicago-style chain Portillo’s Inc. (Nasdaq: PTLO) said total revenue rose 6.9% to $178.3 million for the third quarter, while net income increased $2.2 million to $8.8 million. Earnings per share were $0.11, increasing 83.33% from the prior-year...

Shake Shack Shares Soar After Solid Q3 Sales Growth

Shake Shack Shares Soar After Solid Q3 Sales Growth

By Karen Roman Shake Shack Inc. (NYSE: SHAK) shares rose 7.79% at the closing after the company declared revenue grew 14.7% for the third quarter and same-store sales increased 4.4%, beating analysts’ expectations. This is the 15th consecutive quarter of...

DecisionRx Appoints Michael Tilton as Chief Growth Officer

DecisionRx Appoints Michael Tilton as Chief Growth Officer

By Karen Roman DecisionRx said it appointed Michael Tilton as Chief Growth Officer to lead the expansion of the company’s Medication Therapy Optimization platform. Tilton’s previous roles include senior vice president at Humana, as well as other senior leadership positions...

Input your search keywords and press Enter.